Last reviewed · How we verify

NCT03576703

Sugar-sweetened Beverages Influence Benefits of Exercise in Overweight Adults

Completed NA Last updated 3 July 2018
What this trial tests

NA trial testing Exercise with and without SSB ingestion in Inflammation in 26 participants. Completed in 9 July 2015.

Timeline
24 October 2014
Primary endpoint
9 July 2015
9 July 2015

Quick facts

Lead sponsorMontana State University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeprevention
Enrollment26
Start date24 October 2014
Primary completion9 July 2015
Estimated completion9 July 2015

Drugs / interventions tested

Conditions studied

Sponsor

Montana State University

Who can join

Adults 18 to 55, any sex, with Inflammation or Insulin Sensitivity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study was to determine how metabolic and inflammatory effects of physical exercise in overweight individuals are altered when sugar-sweetened beverages (SSB) are consumed after physical exercise. A randomized, controlled crossover trial was performed in which participants performed exercise with and without the ingestions of SSB during exercise or a non-exercise control condition to evaluate metabolic and inflammatory responses one day after the exercise and or SSB treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Inflammation

Currently open trials in the same condition.

Other Montana State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03576703.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing